Multicomponent Intervention Study- Blood Donors With High Cholesterol

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-75

SponsorUniversity of Texas Southwestern Medical Center

About this trial

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria

Age 18 to 75 years

Currently taking medication to lower cholesterol

Taking any medication that can interact with statins

Pregnancy

Identified secondary cause of elevated lipids

100 Participants

are divided into 2 treatment groups

University of Texas Southwestern Medical Center

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator